Guizhou Bailing Group Pharmaceutical Co., Ltd. (SZSE: 002424)
Health Care · Pharmaceuticals · CN
CN¥4.69
+1.74% today · -10.8% 1Y
Guizhou Bailing Group Pharmaceutical Co., Ltd. (SZSE: 002424) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $954.40M and employs 5,715 people.
Over the last twelve months the share price has lost 10.8%, trading between 4.08 and 6.43.
Tweenvest scores Guizhou Bailing Group Pharmaceutical Co., Ltd. across four factors: quality 71/100, value 53/100, growth 25/100. Its strongest factor is quality.
002424 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $954.40M
- Revenue (TTM)
- $376.45M
- P/E
- —
- EPS
- -0.09
- Dividend yield
- —
- Beta (5Y)
- 0.24
- 52-week high
- CN¥6.43
- 52-week low
- CN¥4.08
- Avg volume (3M)
- —
- Shares outstanding
- 1.37B
- Employees
- 5,715
- Next earnings
- —
About Guizhou Bailing Group Pharmaceutical Co., Ltd.
Operating within China, Guizhou Bailing Group Pharmaceutical Co., Ltd. specializes in the full spectrum of activities for traditional Chinese medicine, from initial research and development to manufacturing and market distribution. The company provides a diverse portfolio of medicinal preparations, available in numerous forms including tablets, capsules, granules, liquid syrups, pills, powdered formulations, tinctures, sprays, and topical ointments. These remedies are formulated to address a wide range of health concerns, such as cardiovascular and cerebrovascular conditions, common respiratory issues like coughs and colds, and specific pediatric and gynecological disorders. Established in 2005, its primary operational base is situated in Anshun, China.
- ISIN
- CNE100000PY3
- Founded
- 1999
- Listed since
- Jun 3, 2010
- Exchange
- Shenzhen Stock Exchange
- Currency
- CNY
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Vetoquinol SAENXTPA: VETO | $980.00M | €75.30 | -1.57% |
| Alto Neuroscience, Inc.NYSE: ANRO | $973.20M | $24.03 | -3.10% |
| Kissei Pharmaceutical Co., Ltd.TSE: 4547 | $965.95M | ¥3,695.00 | -0.27% |
| Jenkem Technology Co., Ltd.SHSE: 688356 | $959.79M | CN¥106.41 | +12.26% |
| Luye Pharma Group Ltd.SEHK: 2186 | $931.55M | HK$1.83 | -0.27% |
| Daewoong Pharmaceutical Co., LtdKOSE: A069620 | $931.26M | ₩109,000.00 | +2.64% |
| Youcare Pharmaceutical Group Co., Ltd.SHSE: 688658 | $930.34M | CN¥14.04 | +6.61% |
| Chongqing Pharscin Pharmaceutical Co., Ltd.SZSE: 002907 | $927.60M | CN¥14.90 | +3.26% |
Figures last refreshed Oct 4, 2026.